Page 1 | Search Results | Journal of Experimental Medicine

Skip Nav Destination

1-20 of 33

Sort by

Sort Order Select

Journal Articles

ACKR4 restrains antitumor immunity by regulating CCL21

Carly E. Whyte, Maleika Osman, Ervin E. Kara, Caitlin Abbott, Jade Foeng, Duncan R. McKenzie, Kevin A. Fenix, Yuka Harata-Lee, Kerrie L. Foyle, Sarah T. Boyle, Marina Kochetkova, Amelia Roman Aguilera, Jiajie Hou, Xian-Yang Li, Mark A. Armstrong, Stephen M. Pederson, Iain Comerford, Mark J. Smyth, Shaun R. McColl

J Exp Med (2020) 217 (6): e20190634.

https://doi.org/10.1084/jem.20190634

Published: 14 April 2020

View article titled, ACKR4 restrains antitumor immunity by regulating CCL21

Journal Articles

Donor colonic CD103⁺ dendritic cells determine the severity of acute graft-versus-host disease

J Exp Med (2015) 212 (8): 1303–1321.

https://doi.org/10.1084/jem.20150329

Published: 13 July 2015

View article titled, Donor colonic CD103<sup>+</sup> dendritic cells determine the severity of acute graft-versus-host disease

Includes: Supplementary data

Journal Articles

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Timothy O’Sullivan, Robert Saddawi-Konefka, William Vermi, Catherine M. Koebel, Cora Arthur, J. Michael White, Ravi Uppaluri, Daniel M. Andrews, Shin Foong Ngiow, Michele W.L. Teng, Mark J. Smyth, Robert D. Schreiber, Jack D. Bui

J Exp Med (2012) 209 (10): 1869–1882.

https://doi.org/10.1084/jem.20112738

Published: 27 August 2012

View article titled, Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Journal Articles

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

J Exp Med (2011) 208 (4): 869.

https://doi.org/10.1084/jem.201002692084c

Published: 21 March 2011

View article titled, Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Journal Articles

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

J Exp Med (2011) 208 (3): 491–503.

https://doi.org/10.1084/jem.20100269

Published: 07 March 2011

View article titled, Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Includes: Supplementary data

Journal Articles

Innate immunity defines the capacity of antiviral T cells to limit persistent infection

Daniel M. Andrews, Marie J. Estcourt, Christopher E. Andoniou, Matthew E. Wikstrom, Andrea Khong, Valentina Voigt, Peter Fleming, Hyacinth Tabarias, Geoffrey R. Hill, Robbert G. van der Most, Anthony A. Scalzo, Mark J. Smyth, Mariapia A. Degli-Esposti

J Exp Med (2010) 207 (6): 1333–1343.

https://doi.org/10.1084/jem.20091193

Published: 31 May 2010

View article titled, Innate immunity defines the capacity of antiviral T cells to limit persistent infection

Includes: Supplementary data

Journal Articles

IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses

Michelle A. Linterman, Laura Beaton, Di Yu, Roybel R. Ramiscal, Monika Srivastava, Jennifer J. Hogan, Naresh K. Verma, Mark J. Smyth, Robert J. Rigby, Carola G. Vinuesa

J Exp Med (2010) 207 (2): 353–363.

https://doi.org/10.1084/jem.20091738

Published: 08 February 2010

View article titled, IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses

Includes: Supplementary data

Journal Articles

IL-21 regulates germinal center B cell differentiation and proliferation through a B cell–intrinsic mechanism

Dimitra Zotos, Jonathan M. Coquet, Yang Zhang, Amanda Light, Kathy D'Costa, Axel Kallies, Lynn M. Corcoran, Dale I. Godfrey, Kai-Michael Toellner, Mark J. Smyth, Stephen L. Nutt, David M. Tarlinton

J Exp Med (2010) 207 (2): 365–378.

https://doi.org/10.1084/jem.20091777

Published: 08 February 2010

View article titled, IL-21 regulates germinal center B cell differentiation and proliferation through a B cell–intrinsic mechanism

Includes: Supplementary data

Journal Articles

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

Susan Gilfillan, Christopher J. Chan, Marina Cella, Nicole M. Haynes, Aaron S. Rapaport, Kent S. Boles, Daniel M. Andrews, Mark J. Smyth, Marco Colonna

J Exp Med (2008) 205 (13): 2965–2973.

https://doi.org/10.1084/jem.20081752

Published: 24 November 2008

View article titled, DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

Includes: Supplementary data

Journal Articles

Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells

Irina Caminschi, Fatma Ahmet, Klaus Heger, Jason Brady, Stephen L. Nutt, David Vremec, Suzanne Pietersz, Mireille H. Lahoud, Louis Schofield, Diana S. Hansen, Meredith O'Keeffe, Mark J. Smyth, Sammy Bedoui, Gayle M. Davey, Jose A. Villadangos, William R. Heath, Ken Shortman

J Exp Med (2007) 204 (11): 2579–2590.

https://doi.org/10.1084/jem.20071351

Published: 08 October 2007

View article titled, Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells

Includes: Supplementary data

Journal Articles

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

Joanna R. Groom, Carrie A. Fletcher, Stacey N. Walters, Shane T. Grey, Sally V. Watt, Mathew J. Sweet, Mark J. Smyth, Charles R. Mackay, Fabienne Mackay

J Exp Med (2007) 204 (8): 1959–1971.

https://doi.org/10.1084/jem.20062567

Published: 30 July 2007

View article titled, BAFF and MyD88 signals promote a lupuslike disease independent of T cells

Includes: Supplementary data

Journal Articles

A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition

Lars Kjer-Nielsen, Natalie A. Borg, Daniel G. Pellicci, Travis Beddoe, Lyudmila Kostenko, Craig S. Clements, Nicholas A. Williamson, Mark J. Smyth, Gurdyal S. Besra, Hugh H. Reid, Mandvi Bharadwaj, Dale I. Godfrey, Jamie Rossjohn, James McCluskey

J Exp Med (2006) 203 (3): 661–673.

https://doi.org/10.1084/jem.20051777

Published: 27 February 2006

View article titled, A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition

Includes: Supplementary data

Journal Articles

A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

Masaki Terabe, Jeremy Swann, Elena Ambrosino, Pratima Sinha, Shun Takaku, Yoshihiro Hayakawa, Dale I. Godfrey, Suzanne Ostrand-Rosenberg, Mark J. Smyth, Jay A. Berzofsky

J Exp Med (2005) 202 (12): 1627–1633.

https://doi.org/10.1084/jem.20051381

Published: 19 December 2005

View article titled, A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

Includes: Supplementary data

Journal Articles

Differential antitumor immunity mediated by NKT cell subsets in vivo

Nadine Y. Crowe, Jonathan M. Coquet, Stuart P. Berzins, Konstantinos Kyparissoudis, Rachael Keating, Daniel G. Pellicci, Yoshihiro Hayakawa, Dale I. Godfrey, Mark J. Smyth

J Exp Med (2005) 202 (9): 1279–1288.

https://doi.org/10.1084/jem.20050953

Published: 07 November 2005

View article titled, Differential antitumor immunity mediated by NKT cell subsets in vivo

Includes: Supplementary data

Journal Articles

NKG2D function protects the host from tumor initiation

Mark J. Smyth, Jeremy Swann, Erika Cretney, Nadeen Zerafa, Wayne M. Yokoyama, Yoshihiro Hayakawa

J Exp Med (2005) 202 (5): 583–588.

https://doi.org/10.1084/jem.20050994

Published: 29 August 2005

View article titled, NKG2D function protects the host from tumor initiation

Includes: Supplementary data

Journal Articles

Correction

Mark J. Smyth, Morgan E. Wallace, Stephen L. Nutt, Hideo Yagita, Dale I. Godfrey, Yoshihiro Hayakawa

J Exp Med (2005) 202 (4): 569.

https://doi.org/10.1084/jem.20042280072005c

Published: 08 August 2005

View article titled, Correction

Journal Articles

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

Mark J. Smyth, Morgan E. Wallace, Stephen L. Nutt, Hideo Yagita, Dale I. Godfrey, Yoshihiro Hayakawa

J Exp Med (2005) 201 (12): 1973–1985.

https://doi.org/10.1084/jem.20042280

Published: 20 June 2005

View article titled, Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

Includes: Supplementary data

Journal Articles

NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer

Mark J. Smyth, Jeremy Swann, Janice M. Kelly, Erika Cretney, Wayne M. Yokoyama, Andreas Diefenbach, Thomas J. Sayers, Yoshihiro Hayakawa

J Exp Med (2004) 200 (10): 1325–1335.

https://doi.org/10.1084/jem.20041522

Published: 15 November 2004

View article titled, NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer

Journal Articles

The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene

Ilia Voskoboinik, Marie-Claude Thia, Annette De Bono, Kylie Browne, Erika Cretney, Jacob T. Jackson, Phillip K. Darcy, Stephen M. Jane, Mark J. Smyth, Joseph A. Trapani

J Exp Med (2004) 200 (6): 811–816.

https://doi.org/10.1084/jem.20040776

Published: 13 September 2004

View article titled, The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (<em>PFN1</em>) Gene

Journal Articles

Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells

Shayna E.A. Street, Yoshihiro Hayakawa, Yifan Zhan, Andrew M. Lew, Duncan MacGregor, Amanda M. Jamieson, Andreas Diefenbach, Hideo Yagita, Dale I. Godfrey, Mark J. Smyth

J Exp Med (2004) 199 (6): 879–884.

https://doi.org/10.1084/jem.20031981

Published: 08 March 2004

View article titled, Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells

Includes: Supplementary data

NARROW

ACKR4 restrains antitumor immunity by regulating CCL21

Donor colonic CD103⁺ dendritic cells determine the severity of acute graft-versus-host disease

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Innate immunity defines the capacity of antiviral T cells to limit persistent infection

IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses

IL-21 regulates germinal center B cell differentiation and proliferation through a B cell–intrinsic mechanism

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition

A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

Differential antitumor immunity mediated by NKT cell subsets in vivo

NKG2D function protects the host from tumor initiation

Correction

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer

The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene

Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells

Email alerts

Email alerts

This Feature Is Available To Subscribers Only